Literature DB >> 16704758

The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome.

Li Wei Cho1, Vijay Jayagopal, Eric S Kilpatrick, Stephen Holding, Stephen L Atkin.   

Abstract

BACKGROUND: The luteinizing hormone/follicle stimulating hormone (LH/FSH) ratio is often requested to help diagnose polycystic ovarian syndrome (PCOS) despite a recent consensus recommending against its use. This study aimed to compare the variability of the LH/FSH ratio in PCOS with that of normal menstruating women over a full cycle in order to establish the diagnostic utility, or otherwise, of the test.
METHODS: Twelve women with PCOS and 11 matched controls had blood collected at four-day intervals on 10 consecutive occasions over a complete menstrual cycle.
RESULTS: The median LH/FSH ratio for individual subjects did not differ significantly between the PCOS and the non-affected group (1.6 versus 1.2, P = 0.14). Only 7.6% of samples from PCOS patients had an LH/FSH ratio above three, compared with 15.6% of samples from normal subjects.
CONCLUSION: This study confirms that measurement of the LH/FSH ratio is of limited use in the diagnosis of PCOS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16704758     DOI: 10.1258/000456306776865188

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  11 in total

Review 1.  Clinical characteristics in Taiwanese women with polycystic ovary syndrome.

Authors:  Ming-I Hsu
Journal:  Clin Exp Reprod Med       Date:  2015-09-30

2.  Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome.

Authors:  Sungwook Chun
Journal:  Clin Exp Reprod Med       Date:  2014-06-30

3.  Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome.

Authors:  Chan-Hong Park; Sungwook Chun
Journal:  Obstet Gynecol Sci       Date:  2016-11-15

4.  Prolactin and thyroid stimulating hormone affecting the pattern of LH/FSH secretion in patients with polycystic ovary syndrome: A hospital-based study from North East India.

Authors:  Chandan K Nath; Bhupen Barman; Ananya Das; Purnima Rajkhowa; Polina Baruah; Mriganka Baruah; Arup Baruah
Journal:  J Family Med Prim Care       Date:  2019-01

5.  Elevated and diagnostic androgens of polycystic ovary syndrome.

Authors:  Ibrahim A Abdelazim; Ahmed Alanwar; Mohannad AbuFaza; Osama O Amer; Yerbol Bekmukhambetov; Gulmira Zhurabekova; Svetlana Shikanova; Bakyt Karimova
Journal:  Prz Menopauzalny       Date:  2020-04-27

6.  Common endocrine disorders associated with the polycystic ovary syndrome.

Authors:  Ibrahim A Abdelazim; Osama O Amer; Mohamed Farghali
Journal:  Prz Menopauzalny       Date:  2021-01-07

Review 7.  Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome.

Authors:  Xianqin Qu; Richard Donnelly
Journal:  Int J Mol Sci       Date:  2020-11-01       Impact factor: 5.923

Review 8.  Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment.

Authors:  Chuan Xing; Jiaqi Zhang; Han Zhao; Bing He
Journal:  Int J Womens Health       Date:  2022-02-02

9.  Anthropometric and Biochemical Characteristics of Polycystic Ovarian Syndrome in South Indian Women Using AES-2006 Criteria.

Authors:  Sujatha Thathapudi; Vijayalakshmi Kodati; Jayashankar Erukkambattu; Anuradha Katragadda; Uma Addepally; Qurratulain Hasan
Journal:  Int J Endocrinol Metab       Date:  2014-01-05

10.  Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome.

Authors:  Amar Nagesh Kumar; Jupalle Nagaiah Naidu; Uppala Satyanarayana; Krishnan Ramalingam; Medabalmi Anitha
Journal:  Int J Fertil Steril       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.